1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 15 DECEMBER 2014

Key Pharma News 15 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 29 pages

Industry Trend Analysis - Merck Claims Leadership Of Revived Antibiotics Market With Cubist Acquisition
Industry Trend Analysis - Pfizer Will Become Serious Contender In Immuno-Oncology
Industry Brief - UCB/Daiichi Sankyo To Jointly Commercialise Lacosamide In Japan
Industry Brief - Evotec/Sanofi In Talks For Multi-Component Strategic Collaboration
Industry Brief - Zosano/Lilly Sign ZP-PTH Licensing Deal For Osteoporosis
Industry Brief - Ono/BMS/KHK Enter Immuno-Oncology Clinical Trial Collaboration
Industry Trend Analysis - Takeda's Oncology Rebranding To Reinforce Global Position
Industry Brief - Otsuka To Acquire Avanir Pharmaceuticals
Industry Brief - Pfizer Completes Acquisition Of Baxter's Marketed Vaccines
Industry Brief - Eisai Establishes Holding Company In China
Industry Brief - GSK Not To Pursue Divestment Of Brands In Established Products Portfolio
Industry Trend Analysis - Sun's Acquisition Of Ranbaxy Imminent
Industry Trend Analysis - Rare Diseases Becoming Lucrative Targets
Industry Trend Analysis - New Copaxone Dose Will Soften Impact Of Generics On Teva's Revenues
Industry Brief - EC Approves Lilly's Trulicity For Type II Diabetes
Industry Trend Analysis - FDA CRL A Large Setback For BMS In HCV Market
Industry Trend Analysis - Sales Of Tamiflu and Relenza To Increase Due To Drifted Influenza A Viruses
Industry Brief - Moventig Approved In EU For OIC
Industry Brief - Teva Launches Erlotinib In Canada
Industry Brief - Gilead Faces Lawsuit Over Sovaldi Pricing
Industry Trend Analysis - Novartis' European Flu Vaccine Woes Subside As Italy Lifts Ban
Industry Brief - FDA Approves Sanofi's Priftin For Latent-TB Infection
Industry Brief - GSK Seeks European Approval For Extended Indication Of Volibris
Industry Brief - FDA Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam
Industry Brief - BfArM Accepts Rizaport MAA For Review
Industry Brief - EC Approves Further Indication For Xtandi
Industry Brief - Milestone Triggered As EMA Accepts Application For Imbruvica In WM
Industry Brief - FDA Accepts AstraZeneca's NDA Filing For Iressa
Industry Brief - FDA Approves Xgeva For HCM Refractory To Bisphosphonate Therapy
Industry Brief - Eisai Vies For Levatinib Approval In South Korea
Industry Brief - Sunovion Submits sNDA For Aptiom As MT Treatment Of POS
Industry Brief - FDA Approves Jakafi For Polycythaemia Vera
Industry Brief - First MS Patients In US Receive Genzyme's Lemtrada Following FDA Approval
Industry Brief - Teva Launches Generic Exforge HCT Tablets In US
Industry Brief - Actavis Launches Guanfacine In US
Industry Brief - Daiichi Sankyo Launches New Formulation Of Lixiana In Japan
Industry Brief - Teva, Actavis Launch Celecoxib In US
Industry Trend Analysis - Brivaracetam Will Help UCB Maintain A Strong Position In Epilepsy
Industry Brief - PaxVax Reports Positive Results From Phase III Cholera Vaccine Trial
Industry Trend Analysis - Success Of Biotech Firms With CAR-T Candidates Drawing In Multinationals
Industry Trend Analysis - AstraZeneca/Lilly's Alzheimer's Phase II/III Study Is High Risk/High Reward
Industry Trend Analysis - Second Trial Failure Questions Cabozantinib's Future
Industry Trend Analysis - Gilenya's Failure Will Not Deter Interest In Progressive MS
Industry Trend Analysis - Neratinib's Delayed Filing Shakes Confidence In Puma

Table Of Contents

Key Pharma News 15 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.